The neuropeptide VIP potentiates IL-6 production induced by proinflammatory osteotropic cytokines in calvarial osteoblasts and the osteoblastic cell line MC3T3-E1

Biochemical and Biophysical Research Communications

Volumn 335, Issue 3, 2005, Pages 705-711

  Persson, Emma ^a   Lerner, Ulf H ^a  

^a NONE

Author keywords

Bone; IL 1; IL 6; Osteoblast; VIP

Indexed keywords

CYTOKINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 11; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LUCIFERASE; ONCOSTATIN M; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; BONE METABOLISM; CALVARIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE CONSTRUCT; GENETIC TRANSFECTION; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

3T3 CELLS; ANIMALS; CYTOKINES; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MICE; OSTEOBLASTS; SKULL; VASOACTIVE INTESTINAL PEPTIDE;

EID: 23944471631     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.07.135     Document Type: Article

References (35)

1. G. Karsenty, and E.F. Wagner Reaching a genetic and molecular understanding of skeletal development Dev. Cell 2 2002 389 406
2. S.C. Manolagas The role of IL-6 type cytokines and their receptors in bone Ann. NY Acad. Sci. 840 1998 194 204
3. J. Ahlén, S. Andersson, H. Mukohyama, C. Roth, A. Bäckman, H.H. Conaway, and U.H. Lerner Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones Bone 31 2002 242 251
4. P. Palmqvist, E. Persson, H.H. Conaway, and U.H. Lerner IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae J. Immunol. 169 2002 3353 3362
5. J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in proinflammatory cytokine activity after menopause Endocr. Rev. 23 2002 90 119
6. G.D. Roodman Studies in Paget's disease and their relevance to oncology Semin. Oncol. 28 2001 15 21
7. A. Grey, M.A. Mitnick, U. Masiukiewicz, B.H. Sun, S. Rudikoff, R.L. Jilka, S.C. Manolagas, and K. Insogna A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo Endocrinology 140 1999 4683 4690
8. H. Okada, and S. Murakami Cytokine expression in periodontal health and disease Crit. Rev. Oral Biol. Med. 9 1998 248 266
9. J. Lorenzo, S.L. Sousa, C. Alander, L.G. Raisz, and C.A. Dinarello Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1 Endocrinology 121 1987 1164 1170
10. J.-M. Dayer The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis Joint Bone Spine 69 2002 123 132
11. U.H. Lerner, and P. Lundberg Kinins and neuro-osteogenic factors J.P. Bilezikian L.G. Raisz G.A. Rodan Principles of Bone Biology second ed. 2002 Academic Press New York 773 799
12. P. Lundberg, A. Lie, A. Bjurholm, P.P. Lehenkari, M.A. Horton, U.H. Lerner, and M. Ransjö Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts Bone 27 2000 803 810
13. M. Ransjö, A. Lie, H. Mukohyama, P. Lundberg, and U.H. Lerner Microisolated mouse osteoclasts express VIP-1 and PACAP receptors Biochem. Biophys. Res. Commun. 274 2000 400 404
14. P. Lundberg, I. Lundgren, H. Mukohyama, P.P. Lehenkari, M.A. Horton, and U.H. Lerner VIP/PACAP receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors Endocrinology 142 2001 339 347
15. C. Martinez, M. Delgado, D. Pozo, J. Leceta, J.R. Calvo, D. Ganea, and R.P. Gomariz VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies J. Neuroimmunol. 85 1998 155 167
16. M. Delgado, J. Leceta, and D. Ganea Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia J. Leukoc. Biol. 73 2003 155 164
17. M. Delgado, and D. Ganea Vasoactive intestinal peptide inhibits IL-8 production in human monocytes by downregulating nuclear factor kappaB-dependent transcriptional activity Biochem. Biophys. Res. Commun. 302 2003 275 283
18. M. Delgado, C. Abad, C. Martinez, J. Leceta, and R.P. Gomariz Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease Nat. Med. 7 2001 563 568
19. M. Delgado, C. Abad, C. Martinez, M.G. Juarranz, A. Arranz, R.P. Gomariz, and J. Leceta Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases J. Mol. Med. 80 2002 16 24
20. E. Persson, O.S. Voznesensky, Y.-F. Huang, U.H. Lerner, Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-κB, in mouse calvarial osteoblasts, Bone (in press).
21. P.M. Boonekamp, J.W. Hekkelman, J.W. Hamilton, D.V. Cohn, and R.L. Jilka Effect of culture on the hormone responsiveness of bone cells isolated by an improved sequential digestion procedure Proc. Kon. Ned. Akad. Wet. 87 1984 371 382
22. P.C. Heinrich, I. Behrmann, G. Müller-Newen, F. Shaper, and L. Graeve Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway Biochem. J. 334 1998 297 314
23. G. Senaldi, B.C. Varnum, U. Sarmiento, C. Starnes, J. Lile, S. Scully, J. Guo, G. Elliott, J. McNinch, C.L. Shaklee, D. Freeman, F. Manu, W.S. Simonet, T. Boone, and M.S. Chang Novel neutrophin-1/B cell stimulatory factor-3: a cytokine of the IL-6 family Proc. Natl. Acad. Sci. USA 96 1999 11458 11463
24. 3 J. Clin. Invest. 91 1993 1731 1742
25. O. Kozawa, A. Suzuki, T. Kaida, H. Tokuda, and T. Uematsu Tumor necrosis factor-α autoregulates IL-6 synthesis via activation of protein kinase C J. Biol. Chem. 272 1997 25099 25104
26. L. Rifas, J.S. Kenney, M. Marcelli, R. Pacifici, S.-L. Cheng, L.L. Dawson, and L.V. Avioli Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids Endocrinology 136 1995 4056 4067
27. H.J. Chae, S.W. Chae, H.Y. Chin, B.G. Bang, S.B. Cho, K.S. Han, S.C. Kim, K.C. Tae, K.H. Lee, D.E. Kim, M.K. Im, S.J. Lee, J.Y. Chang, Y.M. Lee, H.M. Kim, H.H. Kim, Z.H. Lee, and H.R. Kim The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts Bone 28 2001 45 53
28. Y. Nakayama, N. Kato, Y. Nakajima, E. Shimizu, and Y. Ogata Effect of TNF-α on human osteosarcoma cell line Saos2-TNF-α regulation of bone sialoprotein gene expression in Saos2 osteoblast-like cells Cell Biol. Int. 28 2004 653 660
29. R.L. van Bezooijen, H.C.M. Farih-Sips, S.E. Papapoulos, and C.W.G.M. Löwik Interleukin-17: a new bone acting cytokine in vitro J. Bone Miner. Res. 14 1999 1513 1521
30. H. Tokuda, Y. Kanno, A. Ishisaki, M. Takenaka, A. Harada, and O. Kozawa Interleukin (IL)-17 enhances tumor necrosis factor-α-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts J. Cell Biol. 91 2004 1053 1061
31. F. Liu, J.E. Aubin, and L. Malaval Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: Differential regulation by dexamethasone and LIF Bone 31 2002 212 219
32. A. Hernanz, S. Medina, E. Miguel, and E. Martin-Mola Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients Regul. Pept. 115 2003 19 24
33. M.G. Juarranz, B. Santiago, M. Torroba, I. Gutierrez-Canas, G. Palao, M. Galindo, C. Abad, C. Martinez, J. Leceta, J.L. Pablos, and R.P. Gomariz Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells Rheumatology 43 2004 416 422
34. M. Laburthe, and A. Couvineau Molecular pharmacology and structure of VPAC receptors for VIP and PACAP Regul. Pept. 108 2002 165 173
35. D. Vaudry, B.J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions Pharmacol. Rev. 52 2000 269 324